Stifel Financial’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-38,916
| Closed | -$196K | – | 3120 |
|
|
2019
Q3 | $196K | Buy |
38,916
+3,207
| +9% | +$16.2K | ﹤0.01% | 2664 |
|
|
2019
Q2 | $222K | Sell |
35,709
-4,166
| -10% | -$25.9K | ﹤0.01% | 2656 |
|
|
2019
Q1 | $186K | Sell |
39,875
-529
| -1% | -$2.47K | ﹤0.01% | 2608 |
|
|
2018
Q4 | $171K | Buy |
40,404
+19,361
| +92% | +$81.9K | ﹤0.01% | 2490 |
|
|
2018
Q3 | $131K | Sell |
21,043
-514
| -2% | -$3.2K | ﹤0.01% | 2650 |
|
|
2018
Q2 | $172K | Sell |
21,557
-5,506
| -20% | -$43.9K | ﹤0.01% | 2579 |
|
|
2018
Q1 | $202K | Hold |
27,063
| – | – | ﹤0.01% | 2464 |
|
|
2017
Q4 | $161K | Buy |
27,063
+1,500
| +6% | +$8.92K | ﹤0.01% | 2487 |
|
|
2017
Q3 | $188K | Hold |
25,563
| – | – | ﹤0.01% | 2397 |
|
|
2017
Q2 | $174K | Buy |
25,563
+24
| +0.1% | +$163 | ﹤0.01% | 2383 |
|
|
2017
Q1 | $241K | Sell |
25,539
-14,711
| -37% | -$139K | ﹤0.01% | 2221 |
|
|
2016
Q4 | $348K | Buy |
40,250
+15,294
| +61% | +$132K | ﹤0.01% | 1962 |
|
|
2016
Q3 | $157K | Buy |
24,956
+1,505
| +6% | +$9.47K | ﹤0.01% | 2241 |
|
|
2016
Q2 | $99K | Buy |
+23,451
| New | +$99K | ﹤0.01% | 2385 |
|